Key Highlights
- Mirador Therapeutics names Gregg Gilbert as new CFO
- Gregg brings over 25 years of biopharma equity research and investment banking experience
- Previously served as Managing Director at Bank of America Securities
- Focused on advancing Mirador’s precision therapies for immunology and inflammation
- Mirador raised over $400 million since its launch in 2024
Source: Business Wire
Notable Quotes
- “We are thrilled to welcome Gregg at this critical point in our company’s trajectory. Gregg’s impressive Wall Street experience bridges corporate and investor perspectives, and will be invaluable to guiding our next phase of growth.” — Mark C. McKenna, Chairman and CEO at Mirador Therapeutics
- “I am humbled to join this exceptionally talented and collaborative team as CFO, and look forward to making a meaningful impact as we work to deliver the next wave of precision medicines in I&I.” — Gregg Gilbert, CFO at Mirador Therapeutics
SoHC's Take
The appointment of Gregg Gilbert as CFO at Mirador Therapeutics signifies a strategic move to enhance its financial operations and investor relations as the company accelerates the development of next-generation precision therapies for immunology and inflammation. With over 25 years of experience advising biopharma companies and guiding capital strategies, Gregg’s leadership will be pivotal as Mirador transitions into its next growth phase. This appointment aligns with Mirador’s broader goal of rapidly building a diversified portfolio of transformational therapies.
Heading
In this five-part fireside chat, Dr. Jim Bonnette breaks down the real-world challenges holding health plans back—from fragmented vendor strategies ...
Key Highlights New Mountain Capital is backing SmarterDx at a billion-dollar valuation, according to a source familiar with the transaction.SmarterDx ...
Episode Details: Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Navin Gupta, CEO at Viventium & Hadas Nahon, ...
Episode Details Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio. What you'll get out of ...
Key Highlights Babson Diagnostics partners with Sam’s Clubto expand BetterWay™ blood testingSeven Austin-area Sam’s Club pharmaciesto offer testing, starting with ...
Key Highlights Jeannette Bankes appointed President & CEO, Patient Care SolutionsEffective May 1, 2025, following Tom Westrick’s retirementBrings 30 years of ...
